BIT.BIO DISCOVERY

At bit.bio discovery we strive to develop exciting new technologies for functional genetic screens in iPSCs. We are looking for people who are passionate about our mission and who genuinely care about delivering superior scientific work. Our company culture is fast-paced and collaborative with a strong commitment to excellent science... At bit.bio discovery, a CRISPR perturbation screening platform has been developed to query biology within the context of industry-defining hiPSC derived cellular models. The screening platform is applicable across a wide range of biological questions and disease areas due to the quality and physiological relevance of said models combined with the inherent rigor of the genomic screening approach... By creating and utilising physiological relevant, pure and consistent human cell types, with matched disease models, bit.bio discovery offers customers an ever expanding opportunity to perform CRISPR screens for the discovery and validation of novel drug..

Also known as: BIT BIO Discovery GmbH

Registration numbers: FN 539492x (W)

VAT numbers: ATU75845025

Primary location: Vienna Austria